LEO Pharma Financial Analyst Salaries in New York | Comparably
LEO Pharma is a leading global pharma company read more
EMPLOYEE
PARTICIPANTS
20
TOTAL
RATINGS
176

LEO Pharma Financial Analyst Salaries in New York

The average LEO Pharma Financial Analyst in New York earns an estimated $94,560 annually, which includes an estimated base salary of $85,201 with a $9,359 bonus. LEO Pharma's Financial Analyst compensation is $7,160 more than the US average for a Financial Analyst. Financial Analyst salaries at LEO Pharma in New York can range from $52,000 - $140,000.

In New York, The Finance Department at LEO Pharma earns $5,356 more on average than the Operations Department.

Last updated 4 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$94,560
Average Compensation
$85,201
avg. base
$9,359
avg. bonus

Financial Analyst Salaries at LEO Pharma

In New York, Financial Analysts earn $1,138 more than Financial Analysts, and $14,179 less than Accounting Managers.

Accounting Manager
$109k*
Financial Analyst
$93k*
Accountant
$89k*
Business Analyst
$88k*
Senior Accountant
$85k*
* estimated salary

Compensation at LEO Pharma by Department

In New York, The Finance Department averages $5,356 more than the Operations Department, and $4,712 less than the Marketing Department

Marketing
$88,433 Avg. total comp.
+$5k
Finance
$83,721 Avg. total comp.
Operations
$78,365 Avg. total comp.
-$5k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to LEO Pharma reported making $89,840, while the average male Financial Analyst at similar sized companies reported making $94,632.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to LEO Pharma reported making $97,825, while the average African American/Black Financial Analyst at similar sized companies reported making $68,750.

How Financial Analysts at LEO Pharma Rate Their Compensation

The majority of Financial Analysts at LEO Pharma believe they're not compensated fairly. The majority (67%) of Financial Analysts at LEO Pharma are satisfied with their benefits. See more compensation ratings at LEO Pharma

×
Rate your company